# CT TAVR Abdomen Study

> **NCT05758701** · PHASE4 · RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 164 (estimated)

## Conditions studied

- Transcatheter Aortic Valve Replacement

## Interventions

- **COMBINATION_PRODUCT:** Iodinated Contrast Agent (Omnipaque)
- **DEVICE:** Dual Energy CT

## Key facts

- **NCT ID:** NCT05758701
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-19
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05758701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05758701, "CT TAVR Abdomen Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05758701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*